ANNEE 2018

Publié le 06/02/2019 à 12h16 (mis à jour le 20/02/2019 à 10h51)

PHARMACOÉPIDÉMIOLOGIE, PHARMACOLOGIE SOCIALE, PHARMACOVIGILANCE

Bagheri H. Médicament et cicatrisation. Revue Francophone de cicatrisation. 2018 ;2:22-25.

Béné J, Rousselin C, Bagheri H, Vial T, Gautier S, Lambert M. Nonhemorrhagic joint disorders and vitamin K antagonists : an under-recognized adverse drug reaction ?. Fundam Clin Pharmacol. 2018 ;32:663-668.

Bories P, Lamy S, Simand C, Bertoli S, Delpierre C, Malak S, Fornecker L, Moreau S, Récher C, Nebout A. Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia : results of a national survey. Haematologica. 2018 ;103:2040-2048.

Bouquet É, Star K, Jonville-Béra AP, Durrieu G. Pharmacovigilance in pediatrics.Therapie. 2018 ;73:171-180.

Comont T, Moulis G, Delavigne K, Cougoul P, Parant O, Guyard-Boileau B, Derumeaux H, Adoue D, Beyne-Rauzy O. Re : Severe Primary Autoimmune Thrombocytopenia (ITP) in Pregnancy : a national cohort study Primary immune thrombocytopenia management during pregnancy. A French study. BJOG. 2018 ;125:629-630.

Cool C, Cestac P, McCambridge C, Rouch L, de Souto Barreto P, Rolland Y, Lapeyre-Mestre M. Reducing potentially inappropriate drug prescribing in nursing home residents : effectiveness of a geriatric intervention. Br J Clin Pharmacol. 2018 ;84:1598-1610.

Couderc S, Lapeyre-Mestre M, Bourrel R, Carle P, Montastruc JL, Sommet A. Infectious risk of biological drugs versus traditional systemic treatments in moderate to severe psoriasis : a cohort analysis in the French insurance database. Fundam Clin Pharmacol. 2018 ;32:436-449.

Defer G, Le Caignec F, Fedrizzi S, Montastruc F, Chevanne D, Parienti JJ, Peyro-Saint-Paul L. Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study) : study protocol for a randomized controlled trial.Trials. 2018 ;19:174.

Diaz H, Bagheri H, Palmaro A, Rousseau V, Bourrel R, Montastruc JL, Birebent J. Patterns of direct oral anticoagulant drug prescription in France in 2010-2013 : a study in the Midi-Pyrénées area. Eur J Clin Pharmacol. 2018 ;74:945-951.

Driot D, Figuet L, Birebent J, Coste S, Durrieu G, Jacquot J, Bismuth M. Satisfaction of a pharmacovigilance declaration support network in general practice. Therapie. 2018 ;73:483-493.

Durrieu G, Maupiler M, Rousseau V, Chebane L, Montastruc F, Bondon-Guitton E, Montastruc JL. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children : A Retrospective Analysis from the French Pharmacovigilance Database. Paediatr Drugs. 2018 ;20:81-87.

Essilini A, Comont T, Germain J, Brun N, Dingremont C, Castel B, Arista S, Madaule S, Sailler L, Lapeyre-Mestre M, Beyne-Rauzy O, Godeau B, Adoue D, Moulis G ; CARMEN investigators group. Pretreatment with standard-dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP). Eur J Haematol. 2018 ;100:412-418.

Fuzier R, Serres I, Bourrel R, Palmaro A, Lapeyre-Mestre M. Analgesic Drug Prescription After Carpal Tunnel Surgery : A Pharmacoepidemiological Study Investigating Postoperative Pain. Reg Anesth Pain Med. 2018 ;43:19-24.

Garnier C, Ribes D, Chauveau D, Huart A, Pugnet G, Adoue D, Prevot G, Alric L, Delobel P, Derumeaux H, Mengelle C, Sailler L, Moulis G. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis : Incidence, Risk Factors, and Effect of Antiviral Prophylaxis. J Rheumatol. 2018 ;45:1541-1548.

Guillaume M, Christol C, Plessier A, Corbic M, Péron JM, Sommet A, Rautou PE, Consigny Y, Vinel JP, Valla CD, Bureau C. Bleeding risk of variceal band ligation in extrahepatic portal vein obstruction is not increased by oral anticoagulation. Eur J Gastroenterol Hepatol. 2018 ;30:563-568.

Kaguelidou F, Sommet A, Lapeyre-Mestre M. Use of French healthcare insurance databases in pediatric pharmacoepidemiology. Therapie. 2018 ;73:127-133.

Kaguelidou F, Kassai Koupai B, Durrieu G. Pediatric pharmacology.Therapie. 2018 ;73:111-112.

Khouri C, Lepelley M, Roustit M, Montastruc F, Humbert M, Cracowski JL. Comparative safety of drugs targeting the nitric oxide pathway in pulmonary hypertension : a mixed approach combining a meta-analysis of clinical trials and a disproportionality analysis from the WHO pharmacovigilance database. Chest. 2018 ;154:136-147.

Lafaurie M, Pochard L, Lotiron C, Molinier L, Lapeyre-Mestre M, Jouanjus E. Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital. Clin Drug Investig. 2018 ;38:977-982.

Mahé J, de Campaigno EP, Chené AL, Montastruc JL, Despas F, Jolliet P. Pleural adverse drugs reactions and protein kinase inhibitors : Identification of suspicious targets by disproportionality analysis from VigiBase. Br J Clin Pharmacol. 2018 ;84:2373-2383.

Montastruc F. Intérêt de la pharmaco-épidémiologie dans l’évaluation des médicaments antipsychotiques. Lettre du Pharmacologue. 23018 ;32 :116-119.

Montastruc F, Bénard-Laribière A, Noize P, Pambrun E, Diaz-Bazin F, Tournier M, Bégaud B, Pariente A. Antipsychotics use : 2006-2013 trends in prevalence and incidence and characterization of users. Eur J Clin Pharmacol. 2018 ;74:619-626.

Montastruc F, Benevent J, Touafchia A, Chebane L, Araujo M, Guitton-Bondon E, Durrieu G, Arbus C, Schmitt L, Begaud B, Montastruc JL. Atropinic (Anticholinergic) Burden in Antipsychotic-Treated Patients. Fundam Clin Pharmacol. 2018 ;32:114-119.

Montastruc F, Bagheri H, Lacroix I, Damase-Michel C, Chebane L, Rousseau V, Jouanjus E, Lapeyre-Mestre M, Durrieu G, Montastruc JL. Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP® : A Comparison with Classical Methods of Reporting. Drug Saf. 2018 ;41:511-514.

Montastruc F, Benevent J, Chebane L, Rousseau V, Durrieu G, Sommet A, Montastruc JL. Vomiting and constipation associated with tramadol and codeine : a comparative study in VigiBase®. Eur J Clin Pharmacol. 2018 ;74:1673-1674.

Montastruc F, Khosrow-Khavar F, de Germay S, Renoux C, Rousseau V, Durrieu G, Montastruc M, Rascol O, Sommet A, Lapeyre-Mestre M, Benevent J, Montastruc JL. Tamoxifen and the risk of Parkinsonism : a case/non-case study. Eur J Clin Pharmacol. 2018 ;74:1181-1184.

Montastruc F, Loo SY, Renoux C. Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993-2017. JAMA. 2018 ;320:2149-2151.

Moulis F, Rousseau V, Chebane L, Gouverneur A, Gaboriau L, Faillie JL, Durrieu G, Montastruc F, Montastruc JL. Serious adverse drug reactions with sacubitril/valsartan Entresto® : a French pharmacovigilance survey. Eur J Clin Pharmacol. 2018 ;74:983-84.

Moulis F, Durrieu G, Masmoudi K, Gervoise Boyer M, Rocher F, Montastruc F, Montastruc JL. Medication errors with tramadol drops in children. Eur J Clin Pharmacol. 2018 ;74:247-248.

Moulis F, Durrieu G, Lapeyre-Mestre M. Off-label and unlicensed drug use in children population. Therapie. 2018 ;73:135-149.

Moulis G, Christiansen CF, Darvalics B, Nørgaard M. Prevalence of thrombocytopenia and thrombocytosis upon acute hospital admission to internal medicine units. A cross-sectional study in Denmark. Eur J Intern Med. 2018 ;57:e34-e37.

Moulis G, Germain J, Comont T, Arrouy A, Lapeyre-Mestre M, Adoue D ; CARMEN investigators group. Cardiovascular risk factors in immune thrombocytopenia adults : Results from the CARMEN registry. Am J Hematol. 2018 ;93:E181-E184.

Moulis G, Ibañez B, Palmaro A, Aizpuru F, Millan E, Lapeyre-Mestre M, Sailler L, Cambra K. Cross-national health care database utilization between Spain and France : results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus. Clin Epidemiol. 2018 ;10:863-874.

Mounié M, Costa N, Gauthier M, Palmaro A, Delpierre C, Despas F, Lapeyre-Mestre M, Laurent G, Savy N, Molinier L. Cost evaluation of Chronic Myeloid Leukemia (CML) management in Midi-Pyrenees region : economic impact of different Tyrosine Kinase Inhibitors. JGEM. 2018 ;36:109-122.

Mounié M, Costa N, Sailler L, Lapeyre-Mestre M, Bourrel R, Savy N, Molinier L, Pugnet G. Incremental Costs in Giant Cell Arteritis. Arthritis Care Res (Hoboken). 2018 ;70:1074-1081.

Nguyen TTH, Roussin A, Rousseau V, Montastruc JL, Montastruc F. Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus : A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase. Drug Saf. 2018 ;41:1087-1096.

Nguyen KD, Bagheri B, Bagheri H. Drug-induced bone loss : a major safety concern in Europe. Expert Opin Drug Saf. 2018 ;17:1005-1014.

Nguyen KD, Nguyen PT, Nguyen HA, Roussin A, Montastruc JL, Bagheri H, Olsson S. Overview of Pharmacovigilance System in Vietnam : Lessons Learned in a Resource-Restricted Country. Drug Saf. 2018 ;41:151-159.

Patras de Campaigno E, Kebir I, Montastruc JL, Rueter M, Maret D, Lapeyre-Mestre M, Sallerin B, Despas F. Correction to : Drug-Induced Dental Caries : A Disproportionality Analysis Using Data from VigiBase. Drug Saf. 2018 ;41:827.

Perez C, Olivier P, Lortal B, Duranton S, Montastruc JL, Colin AL, Toulza E, Becker M, Hamy L, Crepin S, Roussillon C, Gimbert A, Petitpain N, Salvo F. Detection of drug safety signals from clinical trials data : Role of SUSARs. Pharmacol Res. 2018 ;131:218-223.

Petitpain N, Argoullon L, Masmoudi K, Fedrizzi S, Cottin J, Latarche C, Mertes PM, Gillet P ; French Network of Regional Pharmacovigilance Centres. Neuromuscular blocking agents induced anaphylaxis : Results and trends of a French pharmacovigilance survey from 2000 to 2012. Allergy. 2018 ;73:2224-2233.

Piel-Julian ML, Mahévas M, Germain J, Languille L, Comont T, Lapeyre-Mestre M, Payrastre B, Beyne-Rauzy O, Michel M, Godeau B, Adoue D, Moulis G ; CARMEN investigators group. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults. J Thromb Haemost. 2018 ;16:1830-1842.

Piel-Julian ML, Moulis G, Fournier P, Dupont R, Geiger D, Astudillo L, Faurie T, Pozzo J, Petermann A, Lairez O, Pugnet G, Sailler L. Early use of anakinra in adult-onset Still’s disease myocarditis. Scand J Rheumatol. 2018 ;47:511-512.

Prat M, Derumeaux H, Sailler L, Lapeyre-Mestre M, Moulis G. Positive predictive values of peripheral arterial and venous thrombosis codes in French hospital database. Fundam Clin Pharmacol. 2018 ;32:108-113.

Revet A, Montastruc F, Raynaud JP, MD, Baricault B, Montastruc JL, Maryse Lapeyre-Mestre M. Trends and Patterns of Antidepressant Use in French Children and Adolescents From 2009 to 2016. A Population-Based Study in the French Health Insurance Database. Journal of Clinical Psychopharmacology. 2018 ;38:327-335.

Reynolds E, Guénette L, Lexchin J, Cassels A, Wilkes MS, Durrieu G, Beaulieu MD, Mintzes B. Reconciling a "pleasant exchange" with evidence of information bias : A three-country study on pharmaceutical sales visits in primary care. Health Policy. 2018 ;122:250-255.

Rioufol C, Lamy S, Conte C, Jeanneau P, Compaci G, Delpierre C, Lapeyre-Mestre M, Laurent G, Despas F. Non-cancer drug consumption during the early trajectory of lymphoma survivorship. Therapie. 2018 ;73:307-317.

Rwagitinywa J, Lapeyre-Mestre M, Bourrel R, Sommet A. Generic antiretroviral drug use in HIV-infected patients : A cohort study from the French health insurance database. Therapie. 2018 ;73:257-266.

Rwagitinywaa J, Sommet A, Palmaro A, Montastruc JL, Lapeyre-Mestre M. Utilization and costs of HIV antiretroviral drugs in Europe during thelast ten years : Impact of generic antiretroviral drugs on cost reduction. Health Policy. 2018 ;122:237-242.

Rwagitinywa J, Lapeyre-Mestre M, Bourrel R, Montastruc JL, Sommet A. Comparison of adherence to generic multi-tablet regimens versus brand multi-tablet and brand single-tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed-dose combinations in HIV-infected patients. Fundam Clin Pharmacol. 2018 ;32:450-458.

Wadelius M, Eriksson N, Kreutz R, Bondon-Guitton E, Ibañez L, Carvajal A, Lucena MI, Sancho Ponce E, Molokhia M, Martin J, Axelsson T, Kohnke H, Yue QY, Magnusson PKE, Bengtsson M, Hallberg P ; EuDAC. Sulfasalazine-induced agranulocytosis is associated with the human leukocyte antigen locus. Clin Pharmacol Ther. 2018 ;103:843-853.

PHARMACOLOGIE CLINIQUE

Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, Ferreira J, Martinez-Martin P, Trenkwalder C, Rascol O. Pain in Parkinson’s disease : facts and uncertainties. Eur J Neurol. 2018 ;25:917-924.

Bagheri H, Sohrabi B, Salarian S, Bagheri B. Lipoglycopeptide antibiotics : reliable fighters against gram-positive pathogens. Arch Clin Infect Dis. 2018 ;13:e59526.

Blanchet PJ, Brefel-Courbon C. Chronic pain and pain processing in Parkinson’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2018 ;87:200-206.

Borm CDJM, Krismer F, Wenning GK, Seppi K, Poewe W, Pellecchia MT, Barone P, Johnsen EL, Østergaard K, Gurevich T, Djaldetti R, Sambati L, Cortelli P, Petrović I, Kostić VS, Brožová H, Růžička E, Marti MJ, Tolosa E, Canesi M, Post B, Nonnekes J, Bloem BR, Rascol O ; European MSA Study Group (EMSA-SG). Axial motor clues to identify atypical parkinsonism : A multicentre European cohort study. Parkinsonism Relat Disord. 2018 ;56:33-40.

Charvin D, Medori R, Hauser RA, Rascol O. Therapeutic strategies for Parkinson disease : beyond dopaminergic drugs. Nat Rev Drug Discov. 2018 ;17:804-822.

Cormier-Dequaire F, Bekadar S, Anheim M, Lebbah S, Pelissolo A, Krack P, Lacomblez L, Lhommée E, Castrioto A, Azulay JP, Defebvre L, Kreisler A, Durif F, Marques-Raquel A, Brefel-Courbon C, Grabli D, Roze E, Llorca PM, Ory-Magne F, Benatru I, Ansquer S, Maltête D, Tir M, Krystkowiak P, Tranchant C, Lagha-Boukbiza O, Lebrun-Vignes B, Mangone G, Vidailhet M, Charbonnier-Beaupel F, Rascol O, Lesage S, Brice A, Tezenas du Montcel S, Corvol JC ; BADGE-PD study group. Suggestive association between OPRM1 and impulse control disorders in Parkinson’s disease. Mov Disord. 2018 ;33:1878-1886.

Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A ; DIGPD Study Group. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology. 2018 ;91:e189-e201.

Dupouy J, Ory-Magne F, Mekies C, Rousseau V, Puel M, Rerat K, Pariente J, Brefel-Courbon C ; PARKMIP group. Cognitive complaint in early Parkinson’s disease : A pilot study. Acta Neurol Scand. 2018 ;137:59-66.

Fabbri M, Ferreira JJ, Lees A, Stocchi F, Poewe W, Tolosa E, Rascol O. Opicapone for the treatment of Parkinson’s disease : A review of a new licensed medicine. Mov Disord. 2018 ;33:1528-1539.

Ferreira JJ, Lees AJ, Poewe W, Rascol O, Rocha JF, Keller B, Soares-da-Silva P. Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease. Neurology. 2018 ;90:e1849-e1857.

Gourdy P, Cazals L, Thalamas C, Sommet A, Calvas F, Galitzky M, Vinel C, Dray C, Hanaire H, Castan-Laurell I, Valet P. Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp. Diabetes Obes Metab. 2018 ;20:157-164.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A. Apomorphine subcutaneous infusion in patients with Parkinson’s disease with persistent motor fluctuations (TOLEDO) : a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2018 ;17:749-759.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P ; EARLYSTIM study group. Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson’s disease with early motor complications (EARLYSTIM trial) : secondary analysis of an open-label randomised trial. Lancet Neurol. 2018 ;17:223-231.

Massabeau C, Khalifa J, Filleron T, Modesto A, Bigay-Gamé L, Plat G, Dierickx L, Aziza R, Rouquette I, Gomez-Roca C, Mounier M, Delord JP, Toulas C, Olivier P, Chatelut E, Mazières J, Cohen-Jonathan Moyal E. Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer : A Phase I Study. Clin Lung Cancer. 2018 ;19:e277-e285.

Moreau C, Duce JA, Rascol O, Devedjian JC, Berg D, Dexter D, Cabantchik ZI, Bush AI, Devos D. FAIRPARK-II study group. Iron as a therapeutic target for Parkinson’s disease. Mov Disord. 2018 ;33:568-574.

Moulis G, Pugnet G, Costedoat-Chalumeau N, Mathian A, Leroux G, Boutémy J, Espitia O, Bouillet L, Berthier S, Gaultier JB, Jeandel PY, Konaté A, Mékinian A, Solau-Gervais E, Terrier B, Wendling D, Andry F, Garnier C, Cathébras P, Arnaud L, Palmaro A, Cacoub P, Amoura Z, Piette JC, Arlet P, Lapeyre-Mestre M, Sailler L. Efficacy and safety of biologics in relapsing polychondritis : a French national multicentre study. Ann Rheum Dis. 2018 ;77:1172-1178.

Ory-Magne F, Pellaprat J, Harroch E, Galitzsky M, Rousseau V, Pavy-Le Traon A, Rascol O, Gerdelat A, Brefel-Courbon C. Abnormal pain perception in patients with Multiple System Atrophy. Parkinsonism Relat Disord. 2018 ;48:28-33.

Pavy-LeTraon A, Brefel-Courbon C, Dupouy J, Ory-Magne F, Rascol O, Senard JM. Combined cardiovascular and sweating autonomic testing to differentiate multiple system atrophy from Parkinson’s disease. Neurophysiol Clin. 2018 ;48:103-110.

Pavy-Le Traon A, Cotterill N, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Rascol O, Martinez-Martin P, Stebbins GT ; Members of the MDS Committee on Rating Scales Development. Clinical Rating Scales for Urinary Symptoms in Parkinson Disease : Critique and Recommendations. Mov Disord Clin Pract. 2018 ;5:479-491.

Péran P, Barbagallo G, Nemmi F, Sierra M, Galitzky M, Traon AP, Payoux P, Meissner WG, Rascol O. MRI supervised and unsupervised classification of Parkinson’s disease and multiple system atrophy. Mov Disord. 2018 ;33:600-608.

Perez-Lloret S, Rascol O. Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia. J Neural Transm (Vienna). 2018 ;125:1237-1250.

Schrag A, Khan K, Hotham S, Merritt R, Rascol O, Graham L. Experience of care for Parkinson’s disease in European countries : a survey by the European Parkinson’s Disease Association. Eur J Neurol. 2018 ;25:1410-1416.

Tesson C, Brefel-Courbon C, Corvol JC, Lesage S, Brice A ; French Parkinson’s Disease Genetics Study Group. LRP10 in α-synucleinopathies. Lancet Neurol. 2018 ;17:1034.

Thobois S, Brefel-Courbon C, Le Bars D, Sgambato-Faure V. Molecular Imaging of Opioid System in Idiopathic Parkinson’s Disease. Int Rev Neurobiol. 2018 ;141:275-303. Walsh RR, Krismer F, Galpern WR, Wenning GK, Low PA, Halliday G, Koroshetz WJ, Holton J, Quinn NP, Rascol O, Shaw LM, Eidelberg D, Bower P, Cummings JL, Abler V, Biedenharn J, Bitan G, Brooks DJ, Brundin P, Fernandez H, Fortier P, Freeman R, Gasser T, Hewitt A, Höglinger GU, Huentelman MJ, Jensen PH, Jeromin A, Kang UJ, Kaufmann H, Kellerman L, Khurana V, Klockgether T, Kim WS, Langer C, LeWitt P, Masliah E, Meissner W, Melki R, Ostrowitzki S, Piantadosi S, Poewe W, Robertson D, Roemer C, Schenk D, Schlossmacher M, Schmahmann JD, Seppi K, Shih L, Siderowf A, Stebbins GT, Stefanova N, Tsuji S, Sutton S, Zhang J. Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting. Neurology. 2018 ;90:74-82.

PHARMACOLOGIE DE LA REPRODUCTION

Bénard-Laribière A, Pambrun E, Sutter-Dallay AL, Gautier S, Hurault-Delarue C, Damase-Michel C, Lacroix I, Bégaud B, Pariente A. Patterns of antidepressant use during pregnancy : a nationwide population-based cohort study. Br J Clin Pharmacol. 2018 ;84:1764-1775.

Danet C, Araujo M, Bos-Thompson MA, Portolan G, Gautier S, Vanlemmens L, Bonenfant S, Jonville-Béra AP, Cottin J, Vial T, Bavoux F, Montastruc JL, Damase-Michel C, Benevent J, Bourgeois-Mondon I, Lacroix I. Pregnancy outcomes in women exposed to cancer chemotherapy. Pharmacoepidemiol Drug Saf. 2018 ;27:1302-1308.

Foch C, Araujo M, Weckel A, Damase-Michel C, Montastruc JL, Benevent J, Durrieu G, Lacroix I. In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database. Int J Pediatr Otorhinolaryngol. 2018 ;113:192-197.

ADDICTOVIGILANCE

Daveluy A, Sauvaget L, Bastien A, Lapeyre-Mestre M, Collin C, Richard N, Haramburu F. Tamper-resistant prescription forms for narcotics in France : Should we generalize them ?. Fundam Clin Pharmacol. 2018 ;32:571-577.

Gentile G, Jego M, Spadari M, Griffiths K, Jouanjus E, Micallef J. Identification and tracking of Addictovigilance signals in general practice : which interactions between the general practitioners and the French Addictovigilance Network ?. Fundam Clin Pharmacol. 2018 ;32:643–651.

Jouanjus E, Guernec G, Lapeyre-Mestre M ; French Addictovigilance Network. Medical prescriptions falsified by the patients : a 12-year national monitoring to assess prescription drug diversion. Fundam Clin Pharmacol. 2018 ;32:306-322.

Jouanjus E, Falcou A, Deheul S, Roussin A, Lapeyre-Mestre M. Detecting the diverted use of psychoactive drugs by adolescents and young adults : A pilot study. Pharmacoepidemiol Drug Saf. 2018 ;27:1286-1292.

Lapeyre-Mestre M. Identification and tracking of addictovigilance signals in general practice : which interactions between the general practitioners and the French addictovigilance network ?. Fundam Clin Pharmacol.2018 ;32:641-642

Micallef J, Dupouey J, Jouve E, Truillet R, Lacarelle B, Taillard J, Daurat A, Authié C, Blin O, Rascol O, Philip P, Mestre D. Cannabis smoking impairs driving performance on the simulator and real driving : a randomized, double-blind, placebo-controlled, crossover trial. Fundam Clin Pharmacol. 2018 ;32:558-570.

Pochard L, Dupouy J, Frauger E, Giocanti A, Micallef J, Lapeyre-Mestre M ; French Addictovigilance Network. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France. Fundam Clin Pharmacol. 2018 ;32:188-197.

Ponté C, Lepelley M, Boucherie Q, Mallaret M, Lapeyre Mestre M, Pradel V, Micallef J. Doctor shopping of opioid analgesics relative to benzodiazepines : A pharmacoepidemiological study among 11.7 million inhabitants in the French countries. Drug Alcohol Depend. 2018 ;187:88-94.

PHARMACOLOGIE FONDAMENTALE

Smolyakov G, Dague E, Roux C, Seguelas MH, Galés C, Senard JM, Arvanitis DN. Nanoscale structural mapping as a measure of maturation in the murine frontal cortex. Brain Struct Funct. 2018 ;223:255-265.

INFORMATIONS SUR LE MEDICAMENT

Bouhanick B, Doucet J, Zulfigar AA, Arcani R, Daumas A, Villani P, Trouvin AP, Perrot S, Benevent J, Montastruc JL, Orlikowski D, Puigrenier S, Yelnik C, Lambert M. Principe du bon usage du médicament et des thérapeutiques non médicamenteuses. La Revue du praticien (item 318). 2018 ;68:e383-e392.

Bouvenot G, Sassard J, Montastruc JL. Pour une utilisation optimale des associations fixes de médicaments. Recommandations de prescription. Bull. Acad. Natle Méd. 2017 ;201:41-44.

El Chaer G, Lapeyre Mestre M. Tramadol : la crise des opioïdes de l’Afrique. Revue Prescrire. 2018 ;418:631.

Montastruc JL. « I have a dream ». Prescrire. 2018 ;38:419.

Revet A, Yrondi A, Montastruc F. Règles de bon usage des benzodiazépines. Presse Med. 2018 ;47:872-877.

Vorspan F, Barré T, Pariente A, Montastruc F, Tournier M. Should the duration of treatment be limited using benzodiazepines ? Presse Med. 2018 ;47:892-898.

DIVERS

Colineaux H, Le Querrec F, Pourcel L, Gallart JC, Azéma O, Lang T, Kelly-Irving M, Charpentier S, Lamy S. Is the use of emergency departments socially patterned ? Int J Public Health. 2018 ;63:397-407.

Massip C, Guet-Revillet H, Grare M, Sommet A, Dubois D. Enhanced culture recovery of Campylobacter with modified Cary-Blair medium : A practical field experience. J Microbiol Methods. 2018 ;149:53-54.

Moulis G, Lapeyre-Mestre M. Score de propension : intérêts, utilisation et limites. Un guide pratique pour le clinicien. Rev Med Interne.2018 ;39:805-812.

Vaysse C, Chantalat E, Beyne-Rauzy O, Morineau L, Despas F, Bachaud JM, Caunes N, Poublanc M, Serrano E, Bugat R, Rougé Bugat ME, Fize AL. The Impact of a Small Private Online Course as a New Approach to Teaching Oncology : Development and Evaluation. JMIR Med Educ. 2018 ;4:e6.

Verga-Gérard A, Afonso M, Bénard A , Chapron A, Chau K, Doussiet E, Guillemin F, Guillo S, Gonthier D, Lafarge S, Lapeyre-Mestre M, Oriol M , Tubach F. Le groupe Soins primaires du réseau Recherche en épidémiologie clinique et en santé publique (RECaP) ; Le groupe Soins primaires du réseau Recherche en épidémiologie clinique et en santé publique (RECaP). Primary care : A definition of the field to develop research.Rev Epidemiol Sante Publique. 2018 ;66:157-162.

Raposo N, Calviere L, Cazzola V, Planton M, Patsoura S, Wargny M, Albucher JF, Sommet A, Olivot JM, Chollet F, Pariente J, Bonneville F, Viguier A. Cortical superficial siderosis and acute convexity subarachnoid hemorrhage in cerebral amyloid angiopathy. Eur J Neurol. 2018 ;25:253-259.

Struhal W, Thijs RD, Pavy-Le Traon A, Wenning G, Senard JM. In memoriam : Sir Roger Bannister 1929-2018. Clin Auton Res. 2018 ;28:351.

Piel-Julian ML, Moulis G, Doumerc N, Seguin P, Astudillo L, Pugnet G, Sailler L. Positional paroxysmal abdominal pain. Rev Med Interne. 2018 ;39:667-668.